Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88,059,438
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
34,726,651
-
Shares change
-
+1,824,891
-
Total reported value, excl. options
-
$820,669,496
-
Value change
-
+$42,947,568
-
Number of buys
-
70
-
Number of sells
-
-30
-
Price
-
$23.64
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2021
117 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q4 2021.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,726,651 shares
of 88,059,438 outstanding shares and own 39.44% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,729,719 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,701,525 shares), Canaan Partners X LLC (2,660,713 shares), Avidity Partners Management LP (2,553,000 shares), RTW INVESTMENTS, LP (2,520,076 shares), FEDERATED HERMES, INC. (2,290,282 shares), BOXER CAPITAL, LLC (2,202,812 shares), STATE STREET CORP (1,692,707 shares), Logos Global Management LP (1,550,000 shares), and VANGUARD GROUP INC (1,514,123 shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.